Vivos Therapeutics Inc (VVOS) Stock Price, Quote & News

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 908 4867

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

Moneyybaggs Jun. 27 at 10:05 PM

$VVOS Upcoming week could see some announcements regarding financing. Needless to say, I’ve LOADED THE BOAT at these levels!!!

0 · Reply

gforce77 Jun. 26 at 4:02 PM

$VVOS for those outside of loopi, I just made my final purchase now and topped off my shares. I like my average price very much and am hoping this is fruitful for all longs out there with me. Good luck and don't get loopi with your game plan know what you own.

1 · Reply

Loopi Jun. 26 at 10:10 AM

$VVOS The chart shows target below -$1 which means the stock will reach after reverse split very soon this year 👇☠️🔴 Good luck ! If not happening i am quitting trading 🤣🔜

1 · Reply

Loopi Jun. 26 at 8:13 AM

$VVOS It you want to buy this wait after Reverse Split because things might go far delisting 😆🔴🗑️🔄❗️

0 · Reply

Loopi Jun. 26 at 8:09 AM

$VVOS Don’t decide to get in unless you read the history of the CEO❗️ I believe seeing $0.17 next month is imminent 🔜☠️🗑️🔴

0 · Reply

kemsma62 Jun. 25 at 11:29 PM

$VVOS Form 8-K https://www.sec.gov/Archives/edgar/data/1716166/000149315226030190/form8-k.htm

0 · Reply

focafoca99 Jun. 25 at 9:32 PM

$VVOS announced an exchange agreement with Streeterville to swap debt for equity and extended its financing deadline to Aug 31.

1 · Reply

Kazeek06 Jun. 25 at 8:21 PM

$VVOS Stuck in the channel. Watching for a either breakout or selloff back into the lower half.

0 · Reply

Loopi Jun. 25 at 8:04 PM

$VVOS Next target 🎯 is $0.26 ❗️🔄

0 · Reply

Loopi Jun. 25 at 6:51 PM

$VVOS 🤣☠️☠️👇🔴🔜

0 · Reply

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

2026-06-11T12:55:08.000Z - 16 days ago

Vivos Therapeutics intends to file registration statement for rights offering

Jun 11, 2026, 8:30 AM EDT - 16 days ago

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

2026-06-10T13:18:43.000Z - 17 days ago

Vivos Therapeutics enters pact with South Palm Cardiovascular Associates

Jun 10, 2026, 9:03 AM EDT - 17 days ago

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Jun 9, 2026, 11:30 AM EDT - 18 days ago

Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase

Jun 8, 2026, 1:39 PM EDT - 19 days ago

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Jun 5, 2026, 8:45 AM EDT - 22 days ago

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

2026-05-20T20:22:09.000Z - 5 weeks ago

Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)

May 20, 2026, 4:10 PM EDT - 5 weeks ago

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 20, 2026, 4:00 PM EDT - 5 weeks ago

Vivos Therapeutics Quarterly report: Q1 2026

May 20, 2026, 4:00 PM EDT - 5 weeks ago

Vivos Therapeutics Earnings release: Q1 2026

May 9, 2026, 11:53 AM EDT - 7 weeks ago

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

ACTU ATAI

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Vivos Therapeutics Registration statement: Registration filing

2026-04-17T13:52:17.000Z - 2 months ago

Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright

2026-04-17T12:43:47.000Z - 2 months ago

Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global

Apr 15, 2026, 5:00 PM EDT - 2 months ago

Vivos Therapeutics Earnings Call Transcript: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 2 months ago

Vivos Therapeutics Earnings release: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 2 months ago

Vivos Therapeutics Annual report: Q4 2025

Apr 15, 2026, 4:20 PM EDT - 2 months ago

Vivos Therapeutics Reports Full Year 2025 Financial Results

Apr 15, 2026, 8:45 AM EDT - 2 months ago

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Apr 7, 2026, 8:45 AM EDT - 2 months ago

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Mar 26, 2026, 8:45 AM EDT - 3 months ago

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

2026-03-17T13:00:18.000Z - 3 months ago

Vivos Therapeutics’ oral medical devices proven to enhance airways

Mar 17, 2026, 8:45 AM EDT - 3 months ago

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Feb 17, 2026, 7:00 AM EST - 4 months ago

Vivos Therapeutics Registration statement: Registration Filing

2026-02-17T11:15:45.000Z - 4 months ago

Vivos Therapeutics files to sell 3.96M shares of common stock for holders

2026-02-05T13:50:40.000Z - 5 months ago

Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology

2026-02-05T13:50:12.000Z - 5 months ago

Vivos Therapeutics signs 12-part media series with New to the Street

Feb 5, 2026, 8:45 AM EST - 5 months ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Jan 20, 2026, 5:31 PM EST - 5 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

2026-01-16T13:10:49.000Z - 5 months ago

Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds

Jan 16, 2026, 8:00 AM EST - 5 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dec 16, 2025, 11:00 AM EST - 6 months ago

Vivos Therapeutics Transcript: Fireside Chat

2025-12-16T13:50:29.000Z - 6 months ago

Vivos Therapeutics opens sleep center in Auburn Hills, Michigan

Dec 16, 2025, 8:45 AM EST - 6 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Nov 19, 2025, 5:00 PM EST - 7 months ago

Vivos Therapeutics Earnings Call Transcript: Q3 2025

Nov 19, 2025, 5:00 PM EST - 7 months ago

Vivos Therapeutics Earnings release: Q3 2025

Nov 19, 2025, 5:00 PM EST - 7 months ago

Vivos Therapeutics Quarterly report: Q3 2025

2025-11-19T21:30:18.000Z - 7 months ago

Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)

Nov 19, 2025, 4:20 PM EST - 7 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 8:30 AM EST - 7 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

2025-11-17T11:15:44.000Z - 7 months ago

Vivos Therapeutics initiated with a Buy at H.C. Wainwright

2025-09-30T12:45:33.000Z - 9 months ago

Vivos Therapeutics announces additional data from use of Vivos DNA device

Sep 30, 2025, 8:30 AM EDT - 9 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 29, 2025, 8:00 AM EDT - 9 months ago

Vivos Therapeutics Proxy statement: Proxy Filing

2025-09-17T12:41:24.000Z - 10 months ago

Vivos Therapeutics announces trial results in pediatric OSA treatment

Sep 17, 2025, 8:30 AM EDT - 10 months ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Sep 5, 2025, 8:00 AM EDT - 10 months ago

Vivos Therapeutics Registration statement: Registration Filing

Aug 19, 2025, 5:00 PM EDT - 11 months ago

Vivos Therapeutics Earnings Call Transcript: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 11 months ago

Vivos Therapeutics Earnings release: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 11 months ago

Vivos Therapeutics Quarterly report: Q2 2025

Aug 19, 2025, 4:20 PM EDT - 11 months ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 8:30 AM EDT - 11 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

2025-07-30T12:50:50.000Z - 11 months ago

Vivos Therapeutics appoints Bruhn as EVP, Jones as SVP

2025-07-01T12:40:14.000Z - 1 year ago

Vivos Therapeutics receives Medicare approval for VidaSleep Oral Applicance

2025-06-26T12:40:25.000Z - 1 year ago

Vivos announces results published of OSA using Daytime-Nighttime Appliance

Jun 26, 2025, 8:30 AM EDT - 1 year ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

2025-06-11T12:35:17.000Z - 1 year ago

Vivos Therapeutics completes acquisition of SCN for $6M in cash, $1.5M in stock

2025-05-20T11:05:21.000Z - 1 year ago

Vivos Therapeutics downgraded to Neutral from Buy at Alliance Global Partners

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Quarterly report: Q1 2025

May 14, 2025, 9:15 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Annual report: Q4 2024

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Feb 18, 2025, 12:00 PM EST - 1 year ago

Vivos Therapeutics Transcript: Fireside Chat

Feb 11, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 29, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 22, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Nov 6, 2024, 7:00 AM EST - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Oct 8, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 7, 2024, 8:00 AM EDT - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 18, 2024, 7:00 AM EDT - 1 year ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Jun 27, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 22, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Annual report: Q4 2023

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Dec 11, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Nov 30, 2023, 7:00 AM EST - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Nov 29, 2023, 11:09 AM EST - 2 years ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 7:44 AM EST - 2 years ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 22, 2023, 7:00 AM EST - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q3 2023

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Quarterly report: Q3 2023

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Earnings release: Q3 2023

Nov 14, 2023, 4:05 PM EST - 2 years ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 9, 2023, 4:30 PM EST - 2 years ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Closes $4 Million Private Placement

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Reverse Stock Split

Moneyybaggs Jun. 27 at 10:05 PM

$VVOS Upcoming week could see some announcements regarding financing. Needless to say, I’ve LOADED THE BOAT at these levels!!!

0 · Reply

gforce77 Jun. 26 at 4:02 PM

1 · Reply

Loopi Jun. 26 at 10:10 AM

$VVOS The chart shows target below -$1 which means the stock will reach after reverse split very soon this year 👇☠️🔴 Good luck ! If not happening i am quitting trading 🤣🔜

1 · Reply

Loopi Jun. 26 at 8:13 AM

$VVOS It you want to buy this wait after Reverse Split because things might go far delisting 😆🔴🗑️🔄❗️

0 · Reply

Loopi Jun. 26 at 8:09 AM

$VVOS Don’t decide to get in unless you read the history of the CEO❗️ I believe seeing $0.17 next month is imminent 🔜☠️🗑️🔴

0 · Reply

kemsma62 Jun. 25 at 11:29 PM

$VVOS Form 8-K https://www.sec.gov/Archives/edgar/data/1716166/000149315226030190/form8-k.htm

0 · Reply

focafoca99 Jun. 25 at 9:32 PM

$VVOS announced an exchange agreement with Streeterville to swap debt for equity and extended its financing deadline to Aug 31.

1 · Reply

Kazeek06 Jun. 25 at 8:21 PM

$VVOS Stuck in the channel. Watching for a either breakout or selloff back into the lower half.

0 · Reply

Loopi Jun. 25 at 8:04 PM

$VVOS Next target 🎯 is $0.26 ❗️🔄

0 · Reply

Loopi Jun. 25 at 6:51 PM

$VVOS 🤣☠️☠️👇🔴🔜

0 · Reply

Loopi Jun. 25 at 6:40 PM

$VVOS Goodbye 🤣🔴🔴❗️❗️Scam driven

0 · Reply

AMP19 Jun. 25 at 5:54 PM

$VVOS Time is your friend when: 1. runway is adequate, almost there.. 2. dilution is manageable, yep 3. catalysts are measurable, yep 4. TAM is large, big check 5. management doesn’t need a home run, just a single. Check 6. Limited liquidity magnifies new demand.

2 · Reply

Loopi Jun. 25 at 5:34 PM

$VVOS you think $0.38 is the bottom nah nah 😆⬇️👇 there will be many bottoms happening next month 🔜🔴🔴

0 · Reply

Loopi Jun. 25 at 5:30 PM

$VVOS stay here for years remember CEO says 2026 cash flow🤣🔴❗️

0 · Reply

KLo24 Jun. 25 at 5:25 PM

$VVOS For as much hate as @Loopi gets on this board he has been more right that wrong. This stock has been a dumpster 🔥📉. hope it turns soon 🥹😭‼️

1 · Reply

ApisEquity Jun. 25 at 5:15 PM

$VVOS loops is just loopin’…r/s doesn’t need to happen until the December 2nd deadline….plenty of time to finish the Streeter financing and selling lock up…

1 · Reply

Loopi Jun. 25 at 4:52 PM

$VVOS See you at $0.23 next week 🔴🔜❗️🔄

0 · Reply

HushMoney Jun. 25 at 2:28 PM

$VVOS 🦗🦗🦗🦗🦗💥

1 · Reply

Loopi Jun. 25 at 1:19 PM

$VVOS Every move is a pre-spilt action. 🔴❗️ Be aware 💀

0 · Reply

Loopi Jun. 25 at 9:28 AM

$VVOS 👇👇 Be careful- Red day all day 🔴❗️

0 · Reply

Loopi Jun. 25 at 8:55 AM

$VVOS Another Red Day 😆🔴❗️❗️ Waiting for entry after Reverse Split 🔄🔜

0 · Reply

Loopi Jun. 24 at 10:00 PM

$VVOS going back to $0.35 🔜🔴

0 · Reply

Market Cap	6.22M
Revenue (ttm)	17.44M
Net Income (ttm)	-21.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121.39%
Debt to Equity Ratio	-6.08

Volume	104,800
Avg Vol	1,772,800
Day's Range	N/A - N/A
Shares Out	13.90M
Stochastic %K	33%
Beta	6.10
Analysts	Sell
Price Target	$2.45